{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T18:46:14Z","timestamp":1794941174750,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Rheumatic Disease Clinics of North America"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.rdc.2017.04.013","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T04:05:09Z","timestamp":1499918709000},"page":"489-502","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":283,"title":["A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes"],"prefix":"10.1016","volume":"43","author":[{"given":"Gretchen","family":"Bandoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Palmsten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chelsey J.","family":"Forbess Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina D.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.rdc.2017.04.013_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00005237-200209000-00004","article-title":"Steroid use during pregnancy","volume":"16","author":"McGee","year":"2002","journal-title":"J\u00a0Perinat Neonatal Nurs"},{"issue":"7","key":"10.1016\/j.rdc.2017.04.013_bib2","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/nrrheum.2009.103","article-title":"Management of RA medications in pregnant patients","volume":"5","author":"Ostensen","year":"2009","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.04.013_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/01.ogx.0000150346.42901.07","article-title":"Corticosteroids, pregnancy, and HELLP syndrome: a review","volume":"60","author":"van Runnard Heimel","year":"2005","journal-title":"Obstet Gynecol Surv"},{"issue":"2","key":"10.1016\/j.rdc.2017.04.013_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/03009740903449313","article-title":"The management of rheumatic diseases in pregnancy","volume":"39","author":"Mitchell","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"10.1016\/j.rdc.2017.04.013_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2826.2008.01663.x","article-title":"The placenta and intrauterine programming","volume":"20","author":"Fowden","year":"2008","journal-title":"J\u00a0Neuroendocrinol"},{"issue":"11","key":"10.1016\/j.rdc.2017.04.013_bib6","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/1440-1681.12009","article-title":"Short- and long-term effects of exposure to natural and synthetic glucocorticoids during development","volume":"39","author":"Singh","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"10.1016\/j.rdc.2017.04.013_bib7","doi-asserted-by":"crossref","first-page":"J287","DOI":"10.1016\/j.jaut.2009.11.015","article-title":"The implications of autoimmunity and pregnancy","volume":"34","author":"Borchers","year":"2010","journal-title":"J\u00a0Autoimmun"},{"issue":"4","key":"10.1016\/j.rdc.2017.04.013_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1542\/peds.8.4.527","article-title":"Production of congenital defects in the offspring of pregnant mice treated with cortisone","volume":"8","author":"Fraser","year":"1951","journal-title":"Pediatrics"},{"issue":"6","key":"10.1016\/j.rdc.2017.04.013_bib9","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/bdra.23248","article-title":"Corticosteroid use and risk of orofacial clefts","volume":"100","author":"Skuladottir","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"4366","key":"10.1016\/j.rdc.2017.04.013_bib10","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.705336","article-title":"Prenatal exposure to prednisone in humans and animals retards intrauterine growth","volume":"202","author":"Reinisch","year":"1978","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.rdc.2017.04.013_bib11","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1002\/art.38874","article-title":"Fetal growth and preterm birth in children exposed to maternal or paternal rheumatoid arthritis. A nationwide cohort study","volume":"66","author":"Rom","year":"2014","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.rdc.2017.04.013_bib12","first-page":"1091","article-title":"Birth outcomes in women with inflammatory bowel disease: effects of disease activity and drug exposure","volume":"20","author":"Broms","year":"2014","journal-title":"Inflamm Bowel Dis"},{"issue":"4","key":"10.1016\/j.rdc.2017.04.013_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10995-006-0073-3","article-title":"Pregnancy outcomes in women with rheumatoid arthritis in Washington State","volume":"10","author":"Reed","year":"2006","journal-title":"Matern Child Health J"},{"key":"10.1016\/j.rdc.2017.04.013_bib14","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm.157.3.157315","article-title":"Efficacy and safety of inhaled corticosteroids. New developments","volume":"157","author":"Barnes","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.rdc.2017.04.013_bib15","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2165\/00003088-199019020-00003","article-title":"Clinical pharmacokinetics of prednisone and prednisolone","volume":"19","author":"Frey","year":"1990","journal-title":"Clin Pharmacokinet"},{"issue":"1","key":"10.1016\/j.rdc.2017.04.013_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0190-9622(92)70162-9","article-title":"Topical glucocorticoids with improved benefit\/risk ratio: do they exist?","volume":"27","author":"Korting","year":"1992","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.rdc.2017.04.013_bib17","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0091-6749(99)70234-4","article-title":"Effects of fluticasone propionate, triamcinolone acetonide, prednisone, and placebo on the hypothalamic-pituitary-adrenal axis","volume":"103","author":"Li","year":"1999","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.rdc.2017.04.013_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000081680","article-title":"Safety and efficacy of fluticasone propionate in the topical treatment of skin diseases","volume":"18","author":"Roeder","year":"2005","journal-title":"Skin Pharmacol Physiol"},{"issue":"9703","key":"10.1016\/j.rdc.2017.04.013_bib19","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60695-4","article-title":"Cleft lip and palate","volume":"374","author":"Mossey","year":"2009","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.rdc.2017.04.013_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1601-0825.2009.01577.x","article-title":"The genetics of isolated orofacial clefts: from genotypes to subphenotypes","volume":"15","author":"Jugessur","year":"2009","journal-title":"Oral Dis"},{"key":"10.1016\/j.rdc.2017.04.013_bib21","series-title":"Smith\u2019s recognizable patterns of human malformation","author":"Jones","year":"2013"},{"key":"10.1016\/j.rdc.2017.04.013_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddx012","article-title":"Imputation of orofacial clefting data identifies novel risk loci and sheds light on the genetic background of cleft lip \u00b1 cleft palate and cleft palate only","author":"Ludwig","year":"2017","journal-title":"Hum Mol Genet"},{"issue":"5","key":"10.1016\/j.rdc.2017.04.013_bib23","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1096-9926(199711)56:5<335::AID-TERA7>3.0.CO;2-W","article-title":"Population-based case-control study of teratogenic potential of corticosteroids","volume":"56","author":"Czeizel","year":"1997","journal-title":"Teratology"},{"issue":"1","key":"10.1016\/j.rdc.2017.04.013_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/(SICI)1096-9926(199807)58:1<2::AID-TERA2>3.0.CO;2-4","article-title":"Corticosteroids during pregnancy and oral clefts: a case-control study","volume":"58","author":"Rodr\u00edguez-Pinilla","year":"1998","journal-title":"Teratology"},{"issue":"3","key":"10.1016\/j.rdc.2017.04.013_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1096-8628(19990917)86:3<242::AID-AJMG9>3.0.CO;2-U","article-title":"Maternal corticosteroid use and risk of selected congenital anomalies","volume":"86","author":"Carmichael","year":"1999","journal-title":"Am J Med Genet"},{"issue":"12","key":"10.1016\/j.rdc.2017.04.013_bib26","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/bdra.10134","article-title":"First trimester exposure to corticosteroids and oral clefts","volume":"67","author":"Pradat","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"issue":"6","key":"10.1016\/j.rdc.2017.04.013_bib27","doi-asserted-by":"crossref","first-page":"585.e1-7","DOI":"10.1016\/j.ajog.2007.05.046","article-title":"Maternal corticosteroid use and orofacial clefts","volume":"197","author":"Carmichael","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"10.1016\/j.rdc.2017.04.013_bib28","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1503\/cmaj.101063","article-title":"Corticosteroid use during pregnancy and risk of orofacial clefts","volume":"183","author":"Hviid","year":"2011","journal-title":"CMAJ"},{"issue":"6","key":"10.1016\/j.rdc.2017.04.013_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/1096-9926(200012)62:6<385::AID-TERA5>3.0.CO;2-Z","article-title":"Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies","volume":"62","author":"Park-Wyllie","year":"2000","journal-title":"Teratology"},{"issue":"2","key":"10.1016\/j.rdc.2017.04.013_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/MJT.0b013e3182491e02","article-title":"Use of corticosteroids in early pregnancy is not associated with risk of oral clefts and other congenital malformations in offspring","volume":"21","author":"Bay Bj\u00f8rn","year":"2014","journal-title":"Am J Ther"},{"issue":"3","key":"10.1016\/j.rdc.2017.04.013_bib31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10654-006-9099-5","article-title":"Oral clefts and life style factors - a case-cohort study based on prospective Danish data","volume":"22","author":"Bille","year":"2007","journal-title":"Eur J Epidemiol"},{"issue":"11","key":"10.1016\/j.rdc.2017.04.013_bib32","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/aje\/kwn065","article-title":"Risk of oral clefts in relation to prepregnancy weight change and interpregnancy interval","volume":"167","author":"Villamor","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.rdc.2017.04.013_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0091-3057(80)90358-5","article-title":"Prenatal exposure to prednisone permanently alters fighting behavior of female mice","volume":"12","author":"Reinisch","year":"1980","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"10.1016\/j.rdc.2017.04.013_bib34","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.berh.2013.07.005","article-title":"Managing lupus patients during pregnancy","volume":"27","author":"Lateef","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"7","key":"10.1016\/j.rdc.2017.04.013_bib35","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/j.1572-0241.2007.01216.x","article-title":"Therapeutic drug use in women with Crohn\u2019s disease and birth outcomes: a Danish nationwide cohort study","volume":"102","author":"N\u00f8rg\u00e5rd","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"10.1016\/j.rdc.2017.04.013_bib36","doi-asserted-by":"crossref","first-page":"3196","DOI":"10.1002\/art.24914","article-title":"Association of higher rheumatoid arthritis disease activity during pregnancy with lower birth weight: results of a national prospective study","volume":"60","author":"De Man","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"14","key":"10.1016\/j.rdc.2017.04.013_bib37","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1177\/0961203310378669","article-title":"Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia","volume":"19","author":"Al Arfaj","year":"2010","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.rdc.2017.04.013_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.reprotox.2003.10.007","article-title":"Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study","volume":"18","author":"Gur","year":"2004","journal-title":"Reprod Toxicol"},{"issue":"6","key":"10.1016\/j.rdc.2017.04.013_bib39","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1016\/j.ajog.2005.02.063","article-title":"Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus","volume":"192","author":"Chakravarty","year":"2005","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"10.1016\/j.rdc.2017.04.013_bib40","doi-asserted-by":"crossref","first-page":"e0129567","DOI":"10.1371\/journal.pone.0129567","article-title":"Inflammatory bowel disease and risk of adverse pregnancy outcomes","volume":"10","author":"Boyd","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.rdc.2017.04.013_bib41","first-page":"329","article-title":"The rising burden of preeclampsia in the United States impacts both maternal and child health","volume":"33","author":"Shih","year":"2016","journal-title":"Am J Perinatol"},{"issue":"1","key":"10.1016\/j.rdc.2017.04.013_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3109\/08916934.2012.730586","article-title":"Laminin-1 (LM-111) in preeclampsia and systemic lupus erythematosus","volume":"46","author":"P\u00e1ez","year":"2013","journal-title":"Autoimmunity"},{"issue":"11","key":"10.1016\/j.rdc.2017.04.013_bib43","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/acr.21807","article-title":"Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia","volume":"64","author":"Palmsten","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"3","key":"10.1016\/j.rdc.2017.04.013_bib44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3109\/14767050903550659","article-title":"The fetal and maternal consequences of gestational diabetes mellitus","volume":"23","author":"Reece","year":"2010","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"issue":"4","key":"10.1016\/j.rdc.2017.04.013_bib45","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1515\/JPM.2006.053","article-title":"Gestational diabetes mellitus in patients receiving long-term corticosteroid therapy during pregnancy","volume":"34","author":"Yildirim","year":"2006","journal-title":"J\u00a0Perinat Med"},{"issue":"3","key":"10.1016\/j.rdc.2017.04.013_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/ecco-jcc\/jjv006","article-title":"Intrapartum corticosteroid use significantly increases the risk of gestational diabetes in women with inflammatory bowel disease","volume":"9","author":"Leung","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"issue":"1","key":"10.1016\/j.rdc.2017.04.013_bib47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2009.03.001","article-title":"A\u00a0most stubborn bias: no adjustment method fully resolves confounding by indication in observational studies","volume":"63","author":"Bosco","year":"2010","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.rdc.2017.04.013_bib48","series-title":"Patterns of prednisone use during pregnancy: daily and cumulative dose [Abstract]","author":"Palmsten","year":"2017"},{"issue":"1","key":"10.1016\/j.rdc.2017.04.013_bib49","first-page":"1","article-title":"The placenta as a mediator of stress effects on neurodevelopmental reprogramming","volume":"41","author":"Bronson","year":"2015","journal-title":"Neuropsychopharmacology"}],"container-title":["Rheumatic Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X17300285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889857X17300285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T11:15:55Z","timestamp":1760181355000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889857X17300285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S0889857X17300285"],"URL":"https:\/\/doi.org\/10.1016\/j.rdc.2017.04.013","relation":{},"ISSN":["0889-857X"],"issn-type":[{"value":"0889-857X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Review of Systemic Corticosteroid Use in Pregnancy and the Risk of Select Pregnancy and Birth Outcomes","name":"articletitle","label":"Article Title"},{"value":"Rheumatic Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rdc.2017.04.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}